<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyRegulatorySummaryOutput xmlns:ns2="local" id="146554"><Title>New Drug Application (supplemental NDA) 201655/002: OPANA ER (oxymorphone hydrochloride) Tablet - Approval Package, 09-Jul-2012</Title><Region>USA</Region><DocCategory>["Reference Document"]</DocCategory><DocType>["Approval Package","NDA","Product Approval Document","Supplemental Approval"]</DocType><Status>Valid</Status></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyRegulatorySummaryOutput>